Cardiawave’s First-in-Human clinical studies results published in The Lancet!

November 17th 2023

📢 Cardiawave is proud to announce the publication of its First-In-Human (FIH) clinical studies results with 40 patients suffering from aortic stenosis treated with its innovative Non-Invasive Ultrasound Therapy (NIUT) device in The Lancet journal! 🚀 
📖 The Lancet is a prestigious medical journal, amongst the oldest and most respected in the world; it is an honour for Cardiawave to have the results of its FIH studies published in The Lancet journal. 
🔬 Our research team’s hard work has paid off, presenting the results of our extensive FIH clinical studies evaluating our innovative NIUT device for the treatment of calcific aortic stenosis. This milestone marks a significant step forward in the combined fields of medical technology, cardiology and patient care.
We would like to express our gratitude to all the researchers, collaborators, patients and partners who have contributed to this project.
💡 Learn more about our research and its potential impact on patient care in The Lancet journal here : []. 
The Lancet Emmanuel Messas Sander IJsselmuiden Danijela Trifunovic Bernard CHOLLEY Etienne Puymirat Jonathan Halim Radmila Karan Menno van Gameren Dusko Terzic @Vladimir Milićević Mickaël Tanter Mathieu Pernot Guillaume Goudot Physics for Medicine Paris #InstitutLangevin CNRS – Centre national de la recherche scientifique ESPCI Paris – PSL Inserm RHU STOP AS #HEGPAP-HP, Assistance Publique – Hôpitaux de Paris Clinical Centre of Serbia Amphia Ziekenhuis
#HeartValveDisease #FocusedUltrasound #MedTech #AorticStenosis #Medtech #FrenchCare #Health20 #NIUT